Moreover, Lcn2 may potentiate the psoriasis development by enhancing Th17- and antimicrobial peptide-mediated inflammation [16], and Lcn2 expression is increased in the periphery and brain in other age-related CNS diseases and their risk factors [17]. Here, LCN2 is linked to psoriasis.